+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating the performance and safety of Artelac Complete MDO eye drops compared to VISMED MULTI eye drops in managing moderate to severe dry eye disease. This study is a double-masked, randomized, parallel group trial aiming to assess whether Artelac is not inferior to VISMED MULTI in treating this condition, focusing on patients with dry eye secondary to specific disorders. Participants self-administer either Artelac Complete MDO or VISMED MULTI eye drops. Prior to randomization, they will use a preservative-free tear substitute for at least 10 days. The study includes a screening period followed by treatment and assessments over approximately 90 days. The primary outcome measure is the change in total OSDI score from baseline to Day 90. Participants will undergo screening to confirm eligibility, including history review and clinical assessments of dry eye severity. During the study, they will be monitored for symptoms and signs of dry eye, with visits at baseline and Day 90 to measure treatment effects. Safety and adherence are tracked throughout, with the total study duration lasting about three months.

Age: 18Years +All GendersPhase Not Applicable
12 locations